실시간
FierceBiotech‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliffLonza NewsSmall-Molecule CDMO Outlook: What Lies Ahead - DCAT Value Chain InsightsClinical OMICsPioneering Innovation in Transplant DiagnosticsFierceBiotechRoche nabs EU approval on label expansions for companion dx platformFierceBiotechGenentech executes another round of layoffs, with 3 VPs axedScienceLaser-boosted microscopes could reveal new drug targets, sharpen views inside cellsScienceThe ocean current that warms Europe may be more resilient than fearedClinical OMICsCyclana Bio Is Exploring the Extracellular Matrix to Treat EndometriosisFierceBiotechAI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data findsRoche MediaGenentech executes another round of layoffs, with 3 VPs axed - Fierce BiotechClinical OMICsHigher Vitamin C Levels in Blood Linked to Healthier Aging BrainsClinical OMICsStopping Neurodegeneration in Place with Vaccines
BioWorld 2026년 3월 10일

Regulatory actions for March 10, 2026

Regulatory actions for March 10, 2026

원문
본문을 이용할 수 없습니다. 원본 출처를 확인하세요.